Anti B7H3 ADC (Lepu Biopharma/Shanghai Miracogen)

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameAnti B7H3 ADC (Lepu Biopharma/Shanghai Miracogen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linker > MCC linker
Mechanisms of ActionAnti-CD276
TargetsCD276 antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLepu Biopharma Co LtdShanghai Miracogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesLepu Biopharma Co LtdShanghai Miracogen Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A